OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
October 18, 2021
Evonik’s LIPEX Flow extruder is a new version of its high-pressure equipment for manufacturing liposomal drug products.
September 01, 2021
Avantor plans to address rising global demand for biologics with their investment in hydration capabilities.
August 25, 2021
AGC Biologics has broken ground on a new multipurpose facility in Copenhagen, Denmark, that will increase capacity.
Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.
August 13, 2021
Rentschler Biopharma has broken ground nearby its Milford, Mass., site where it will build its new multi-product manufacturing facility for commercial production of complex molecules.
August 12, 2021
The Just - Evotec Biologics facility in Redmond, Wash., uses the company’s J.POD technology.
August 03, 2021
Controlling conditions and preventing contamination are crucial for cell growth.
July 22, 2021
Catalent commences the first phase of a $100-million expansion program Anagni site to increase its manufacturing capabilities for biologics drug substance.
July 13, 2021
GEA’s plug-and-produce skids are designed for multi-product pharmaceutical and biopharmaceutical separation.
NewAge Industries is adding cleanrooms at its Pennsylvania headquarters.